Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.55) by 25.45 percent. This is a 19.61 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $1.573 million which beat the analyst consensus estimate of $1.492 million by 5.39 percent. This is a 0.45 percent increase over sales of $1.566 million the same period last year.